Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.50 USD
Change Today 0.00 / 0.00%
Volume 0.0
LCDX On Other Exchanges
As of 8:10 PM 09/30/15 All times are local (Market data is delayed by at least 15 minutes).

lucid inc (LCDX) Key Developments

Caliber Imaging & Diagnostics Appoints William F. O'dell to its Board of Directors

Caliber Imaging & Diagnostics has appointed William F. O'Dell to its Board of Directors, effective immediately. Mr. O'Dell joins Caliber's Board of Directors as it revamps its global sales and marketing program. Most recently, Mr. O'Dell was Executive Vice President--Sales & Marketing at DUSA Pharmaceuticals, Inc.

Caliber Imaging & Diagnostics, Inc. Presents at Third Annual Marcum MicroCap Conference, May-29-2014 04:30 PM

Caliber Imaging & Diagnostics, Inc. Presents at Third Annual Marcum MicroCap Conference, May-29-2014 04:30 PM. Venue: Grand Hyatt New York, 109 East 42nd Street, New York, NY 10017, United States.

Caliber Imaging & Diagnostics Appoints Joseph R. Williams as First Vice President of Global Marketing

Caliber Imaging & Diagnostics appointed Joseph R. Williams as Vice President of Global Marketing, a newly created position, effective immediately. Before arriving at Caliber I.D., Mr. Williams was Director of Market Development at Axsun Technologies/Volcano Corporation, where he led the creation and execution of strategies focused on the development and application of Optical Coherence Tomography (OCT) and other imaging technologies.

Caliber Imaging & Diagnostics Announces Executive Change

Caliber Imaging & Diagnostics has named Richard C. Christopher as Chief Financial Officer, effective immediately. Mr. Christopher replaces Richard J. Pulsifer. Mr. Christopher served for eight years as Chief Financial Officer of DUSA Pharmaceuticals, Inc., until its sale to Sun Pharmaceuticals Industries Limited in 2012.

Caliber Imaging & Diagnostics, Inc. Names Daniel Koon to Director of Global Sales Support

Caliber Imaging & Diagnostics, Inc. has named Daniel Koon to Director of Global Sales Support, effective immediately. Mr. Koon most recently served as Caliber I.D.'s Research Sales Manager, and prior to that held other positions within the company. Mr. Koon has experience in international sales and support of Caliber's VivaScope(R) devices for research applications in clinical and preclinical dermatology. He has spent extended periods in Europe to help develop and implement strategies to assist the company's European distribution partner MAVIG GmbH.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCDX:US $0.50 USD 0.00

LCDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Guided Therapeutics Inc $0.05 USD -0.0025
Mauna Kea Technologies €2.95 EUR +0.03
MedX Health Corp C$0.10 CAD +0.005
MELA Sciences Inc $1.14 USD +0.02
Verisante Technology Inc C$0.07 CAD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation LCDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LUCID INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at